Advertisement
No access
Report

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

Science
20 May 1983
Vol 220, Issue 4599
pp. 868-871

Abstract

A retrovirus belonging to the family of recently discovered human T-cell leukemia viruses (HTLV), but clearly distinct from each previous isolate, has been isolated from a Caucasian patient with signs and symptoms that often precede the acquired immune deficiency syndrome (AIDS). This virus is a typical type-C RNA tumor virus, buds from the cell membrane, prefers magnesium for reverse transcriptase activity, and has an internal antigen (p25) similar to HTLV p24. Antibodies from serum of this patient react with proteins from viruses of the HTLV-I subgroup, but type-specific antisera to HTLV-I do not precipitate proteins of the new isolate. The virus from this patient has been transmitted into cord blood lymphocytes, and the virus produced by these cells is similar to the original isolate. From these studies it is concluded that this virus as well as the previous HTLV isolates belong to a general family of T-lymphotropic retroviruses that are horizontally transmitted in humans and may be involved in several pathological syndromes, including AIDS.

Get full access to this article

View all available purchase options and get full access to this article.

References

MORBIDITY AND MORTALITY WEEKLY REPORT 31: 507 (1982).
NEW ENGLAND JOURNAL OF MEDICINE 306: 248 (1982).
BARRESINOUSSI, F, ENHANCEMENT OF RETROVIRUS PRODUCTION BY ANTI-INTERFERON SERUM, ANNALES DE MICROBIOLOGIE 130: 349 (1979).
FANNIN, S, MMWR 31: 305 (1982).
GALLO, R.C., HUMAN RETROVIRUSES AND ADULT T-CELL LEUKEMIA LYMPHOMA, JOURNAL OF THE NATIONAL CANCER INSTITUTE 69: 1209 (1982).
GELMANN, E, COMMUNICATION.
KALYANARAMAN, V.S., IMMUNOLOGICAL PROPERTIES OF A TYPE-C RETROVIRUS ISOLATED FROM CULTURED HUMAN T-LYMPHOMA CELLS AND COMPARISON TO OTHER MAMMALIAN RETROVIRUSES, JOURNAL OF VIROLOGY 38: 906 (1981).
KALYANARAMAN, V.S., A NEW SUBTYPE OF HUMAN T-CELL LEUKEMIA-VIRUS (HTLV-II) ASSOCIATED WITH A T-CELL VARIANT OF HAIRY-CELL LEUKEMIA, SCIENCE 218: 571 (1982).
KARESS, R.E., CELLULAR INFORMATION IN THE GENOME OF RECOVERED AVIAN-SARCOMA VIRUS DIRECTS THE SYNTHESIS OF TRANSFORMING PROTEIN, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 76: 3154 (1979).
LAEMMLI, U.K., NATURE 227: 608 (1970).
MARMOR, M, RISK-FACTORS FOR KAPOSIS SARCOMA IN HOMOSEXUAL MEN, LANCET 1: 1083 (1982).
MILDVAN, D, MORBIDITY AND MORTALITY WEEKLY REPORT 31: 249 (1982).
OREILLY, R, MORBIDITY AND MORTALITY WEEKLY REPORT 31: 665 (1982).
Poiesz, B. J., Proceedings of the National Academy of Sciences of the United States of America 77: 7415 (1980).
POON, M.C., MORBIDITY AND MORTALITY WEEKLY REPORT 31: 644 (1982).
POPOVIC, M, ISOLATION AND TRANSMISSION OF HUMAN RETROVIRUS (HUMAN T-CELL LEUKEMIA-VIRUS), SCIENCE 219: 856 (1983).
ROBERTGUROFF, M, DETECTION OF THE HUMAN T-CELL LYMPHOMA VIRUS P19 IN CELLS OF SOME PATIENTS WITH CUTANEOUS T-CELL LYMPHOMA AND LEUKEMIA USING A MONOCLONAL-ANTIBODY, JOURNAL OF EXPERIMENTAL MEDICINE 154: 1957 (1981).
ROZENBAUM, W, MULTIPLE OPPORTUNISTIC INFECTION IN A MALE-HOMOSEXUAL IN FRANCE, LANCET 1: 572 (1982).
STAHL, R.E., IMMUNOLOGICAL ABNORMALITIES IN HOMOSEXUAL MEN - RELATIONSHIP TO KAPOSI SARCOMA, AMERICAN JOURNAL OF MEDICINE 73: 171 (1982).

(0)eLetters

eLetters is a forum for ongoing peer review. eLetters are not edited, proofread, or indexed, but they are screened. eLetters should provide substantive and scholarly commentary on the article. Embedded figures cannot be submitted, and we discourage the use of figures within eLetters in general. If a figure is essential, please include a link to the figure within the text of the eLetter. Please read our Terms of Service before submitting an eLetter.

Log In to Submit a Response

No eLetters have been published for this article yet.

Information & Authors

Information

Published In

Science
Volume 220 | Issue 4599
20 May 1983

Submission history

Published in print: 20 May 1983

Permissions

Request permissions for this article.

Authors

Affiliations

F. Barré-Sinoussi
Institut Pasteur, Département de Virologie, 75724 Paris Cédex 15
J. C. Chermann
Institut Pasteur, Département de Virologie, 75724 Paris Cédex 15
F. Rey
Institut Pasteur, Département de Virologie, 75724 Paris Cédex 15
M. T. Nugeyre
Institut Pasteur, Département de Virologie, 75724 Paris Cédex 15
S. Chamaret
Institut Pasteur, Département de Virologie, 75724 Paris Cédex 15
J. Gruest
Institut Pasteur, Département de Virologie, 75724 Paris Cédex 15
C. Dauguet
Institut Pasteur, Département de Virologie, 75724 Paris Cédex 15
C. Axler-Blin
Institut Pasteur, Département de Virologie, 75724 Paris Cédex 15
F. Vézinet-Brun
Hôpital Claude Bernard, Laboratoire Central-Virologie, 75019 Paris
C. Rouzioux
Hôpital Claude Bernard, Laboratoire Central-Virologie, 75019 Paris
W. Rozenbaum
Hôpital La Pitié-Salpétrière, Département de Santé Publique et Médecine Tropicale, 75013 Paris
L. Montagnier
Institut Pasteur, Département de Virologie, 75724 Paris Cédex 15

Metrics & Citations

Metrics

Article Usage

Altmetrics

Citations

Cite as

Export citation

Select the format you want to export the citation of this publication.

Cited by

  1. Antiretroviral treatment for HIV infection and AIDS, Journal of the Korean Medical Association, 67, 3, (173-178), (2024).https://doi.org/10.5124/jkma.2024.67.3.173
    Crossref
  2. Friends and Foes: The Ambivalent Role of Autophagy in HIV-1 Infection, Viruses, 16, 4, (500), (2024).https://doi.org/10.3390/v16040500
    Crossref
  3. Evolution of Virology: Science History through Milestones and Technological Advancements, Viruses, 16, 3, (374), (2024).https://doi.org/10.3390/v16030374
    Crossref
  4. Precise Therapy Using the Selective Endogenous Encapsidation for Cellular Delivery Vector System, Pharmaceutics, 16, 2, (292), (2024).https://doi.org/10.3390/pharmaceutics16020292
    Crossref
  5. A Bilayer Microarray Patch (MAP) for HIV Pre-Exposure Prophylaxis: The Role of MAP Designs and Formulation Composition in Enhancing Long-Acting Drug Delivery, Pharmaceutics, 16, 1, (142), (2024).https://doi.org/10.3390/pharmaceutics16010142
    Crossref
  6. Marine-Derived Bioactive Metabolites as a Potential Therapeutic Intervention in Managing Viral Diseases: Insights from the SARS-CoV-2 In Silico and Pre-Clinical Studies, Pharmaceuticals, 17, 3, (328), (2024).https://doi.org/10.3390/ph17030328
    Crossref
  7. New Insights into HIV Life Cycle, Th1/Th2 Shift during HIV Infection and Preferential Virus Infection of Th2 Cells: Implications of Early HIV Treatment Initiation and Care, Life, 14, 1, (104), (2024).https://doi.org/10.3390/life14010104
    Crossref
  8. Clinical, epidemiological, and drug resistance insights into HIV-positive patients in Meizhou, China, Frontiers in Cellular and Infection Microbiology, 13, (2024).https://doi.org/10.3389/fcimb.2023.1330826
    Crossref
  9. Four Decades of HIV: Global Trends, Testing Assays, Treatment, and Challenges, Zoonoses, 4, 1, (2024).https://doi.org/10.15212/ZOONOSES-2023-0039
    Crossref
  10. Synthesis, anti-HIV and cytotoxicity evaluation of chiral 2,5-disubstituted 1,3,4-thiadiazole derivatives bearing the sulfonamide scaffold, Zeitschrift für Naturforschung B, 79, 2-3, (89-97), (2024).https://doi.org/10.1515/znb-2023-0078
    Crossref
  11. See more
Loading...

View Options

Check Access

Log in to view the full text

AAAS ID LOGIN

AAAS login provides access to Science for AAAS Members, and access to other journals in the Science family to users who have purchased individual subscriptions.

Log in via OpenAthens.
Log in via Shibboleth.

More options

Purchase digital access to this article

Download and print this article for your personal scholarly, research, and educational use.

Purchase this issue in print

Buy a single issue of Science for just $15 USD.

View options

PDF format

Download this article as a PDF file

Download PDF

Media

Figures

Multimedia

Tables

Share

Share

Share article link

Share on social media